NHC:NYE-National HealthCare Corporation (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 92.83

Change

0.00 (0.00)%

Market Cap

USD 1.90B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-08 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

N/A

USD 81.54B
DVA DaVita HealthCare Partners Inc

N/A

USD 12.59B
THC Tenet Healthcare Corporation

N/A

USD 12.13B
UHS Universal Health Services Inc

N/A

USD 11.22B
EHC Encompass Health Corp

N/A

USD 10.00B
CHE Chemed Corp

N/A

USD 8.72B
CON Concentra Group Holdings Paren..

N/A

USD 2.93B
ARDT Ardent Health Partners, Inc.

N/A

USD 2.59B
AGL agilon health Inc

N/A

USD 1.41B
GRDN Guardian Pharmacy Services, In..

N/A

USD 1.25B

ETFs Containing NHC

COAL Exchange Traded Concepts .. 4.71 % 0.00 %

N/A

USD 0.01B
SDGPEX:SW iShares STOXX Global Sele.. 2.12 % 0.00 %

N/A

N/A
D100:XETRA 2.01 % 0.00 %

N/A

N/A
MVS:AU VanEck Vectors Small Comp.. 1.94 % 0.00 %

N/A

USD 0.07B
DESC 0.00 % 0.30 %

N/A

N/A
KOL 0.00 % 0.60 %

N/A

N/A
ISPA:F iShares (DE) I - iShares .. 0.00 % 0.00 %

N/A

N/A
ISPA:XETRA iShares STOXX Global Sele.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -13.69% 19% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.69% 19% F 11% F
Trailing 12 Months  
Capital Gain 0.31% 50% F 42% F
Dividend Return 2.62% 70% C- 43% F
Total Return 2.93% 64% D 38% F
Trailing 5 Years  
Capital Gain 28.72% 47% F 51% F
Dividend Return 15.54% 100% F 43% F
Total Return 44.26% 59% D- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 17.89% 64% D 79% B-
Dividend Return 21.07% 64% D 80% B-
Total Return 3.18% 100% F 65% D
Risk Return Profile  
Volatility (Standard Deviation) 35.06% 59% D- 29% F
Risk Adjusted Return 60.11% 86% B+ 73% C
Market Capitalization 1.90B 62% D 66% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Underpriced on free cash flow basis

The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.